Simultaneously, JPJDR, a traditional Chinese medicine compound, inhibits fibroblast activation and reduces CRC liver metastasis by blocking the ITGBL1-rich EV-mediated TNFAIP3-NF-κB pathway (38). Here, NFKB1 is linked to colorectal carcinoma.